NCT04414813 Stereotactic Transplantation of hAESCs for Parkinson's Disease Status COMPLETED Phase EARLY_PHASE1
NCT04403399 Crossover Target Engagement Study of Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease (Project #3 - Experiment 3 [UdallP3E3]) Status COMPLETED Phase PHASE2
NCT04396873 PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease Status RECRUITING Phase PHASE1
NCT04366804 International Validation of Two Non-motor Scales in PD (NFS and SPARK) Status RECRUITING Phase N/A
NCT04308135 Differences Between Patients With Vascular Parkinsonism and Parkinson's Disease Status COMPLETED Phase N/A
NCT04297800 Gait Characteristics and Cognitive Evolution in Parkinson Disease Status COMPLETED Phase N/A
NCT04275492 Study on Bioequivalence of Pramipexole Dihydrochloride Sustained Release Tablets Status TERMINATED Phase NA
NCT04232969 Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease Status COMPLETED Phase PHASE3
NCT04228172 Genotypic Influences on Network Progression in Parkinson's Disease Status ACTIVE_NOT_RECRUITING Phase N/A
NCT04204551 Effect of High Intensity Interval Training on Mechanisms of Neuroplasticity in Parkinson's Disease Patients Status UNKNOWN Phase NA
NCT04179695 Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care Status RECRUITING Phase NA
NCT04165837 Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT04164758 Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine Status TERMINATED Phase PHASE2
NCT04164043 Efficacy of a Recreation Therapy Wellness Recovery Program for Individuals With Parkinson's Disease Status TERMINATED Phase NA
NCT04157933 Staccato Apomorphine Multi-dose PK and PD in Patients With Parkinson's Disease Status COMPLETED Phase PHASE1
NCT04127695 A Study to Evaluate the Safety and Tolerability of ABBV-0805 in Patients With Parkinson's Disease Status WITHDRAWN Phase PHASE1